Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer

[1]  Sriganesh Srihari,et al.  Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer , 2016, Molecular oncology.

[2]  Jean-Philippe Vert,et al.  Changes in correlation between promoter methylation and gene expression in cancer , 2015, BMC Genomics.

[3]  Jun S. Liu,et al.  Inference of transcriptional regulation in cancers , 2015, Proceedings of the National Academy of Sciences.

[4]  Sarah Watson,et al.  Pragmatic issues in biomarker evaluation for targeted therapies in cancer , 2015, Nature Reviews Clinical Oncology.

[5]  I. Ellis,et al.  DNA damage response markers are differentially expressed in BRCA-mutated breast cancers , 2015, Breast Cancer Research and Treatment.

[6]  M. Ritchie,et al.  Methods of integrating data to uncover genotype–phenotype interactions , 2015, Nature Reviews Genetics.

[7]  Yu Shyr,et al.  Transcriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity , 2014, Genome Medicine.

[8]  E. Lam,et al.  FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance , 2014, Biochimica et biophysica acta.

[9]  Qi Liu,et al.  Transcriptome-wide signatures of tumor stage in kidney renal clear cell carcinoma: connecting copy number variation, methylation and transcription factor activity , 2014, Genome Medicine.

[10]  Zhaolei Zhang,et al.  Regression Analysis of Combined Gene Expression Regulation in Acute Myeloid Leukemia , 2014, PLoS Comput. Biol..

[11]  G. Chenevix-Trench,et al.  A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy , 2014, Nucleic acids research.

[12]  A. Frigessi,et al.  Principles and methods of integrative genomic analyses in cancer , 2014, Nature Reviews Cancer.

[13]  Ralph R. Weichselbaum,et al.  DNA Repair Pathway Gene Expression Score Correlates with Repair Proficiency and Tumor Sensitivity to Chemotherapy , 2014, Science Translational Medicine.

[14]  A. Nag,et al.  CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases , 2014, Open Biology.

[15]  M. Okoniewski,et al.  A comprehensive look at transcription factor gene expression changes in colorectal adenomas , 2014, BMC Cancer.

[16]  H. Iwase,et al.  Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival , 2013, BMC Cancer.

[17]  Eleni G. Christodoulou,et al.  Assessing Computational Methods for Transcription Factor Target Gene Identification Based on ChIP-seq Data , 2013, PLoS Comput. Biol..

[18]  M. Ruíz-Borrego,et al.  Prognostic value of CtIP/RBBP8 expression in breast cancer , 2013, Cancer medicine.

[19]  Lajos Pusztai,et al.  DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes. , 2013, The oncologist.

[20]  Byoung-Tak Zhang,et al.  Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer , 2013, Nucleic acids research.

[21]  J. Benítez,et al.  Analysis of DNA Repair–Related Genes in Breast Cancer Reveals CUL4A Ubiquitin Ligase as a Novel Biomarker of Trabectedin Response , 2013, Molecular Cancer Therapeutics.

[22]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[23]  Yong Lin,et al.  FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. , 2012, Acta histochemica.

[24]  Nicola J. Curtin,et al.  DNA repair dysregulation from cancer driver to therapeutic target , 2012, Nature Reviews Cancer.

[25]  B. Maher.  ENCODE: The human encyclopaedia , 2012, Nature.

[26]  Manu Setty,et al.  Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma , 2012, Molecular systems biology.

[27]  Peter Bouwman,et al.  The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance , 2012, Nature Reviews Cancer.

[28]  Ronald A. Li,et al.  The B-MYB Transcriptional Network Guides Cell Cycle Progression and Fate Decisions to Sustain Self-Renewal and the Identity of Pluripotent Stem Cells , 2012, PloS one.

[29]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[30]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[31]  A. D’Andrea,et al.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. , 2012, Genes & development.

[32]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[33]  A. D’Andrea,et al.  A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy , 2012, Journal of the National Cancer Institute.

[34]  David G Johnson,et al.  Transcriptional and nontranscriptional functions of E2F1 in response to DNA damage. , 2012, Cancer research.

[35]  Jie Zhou,et al.  Discovering transcription factor regulatory targets using gene expression and binding data , 2012, Bioinform..

[36]  Melissa J. Davis,et al.  Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets , 2012, Genome Medicine.

[37]  W. El-Rifai,et al.  p73 protein regulates DNA damage repair , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  U. Schüller,et al.  Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients , 2011, Clinical Cancer Research.

[39]  M. Toulmonde,et al.  A review of PARP inhibitors: from bench to bedside. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  M. Hedayati,et al.  Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor , 2010, PloS one.

[41]  Stefano Piccolo,et al.  MicroRNA control of signal transduction , 2010, Nature Reviews Molecular Cell Biology.

[42]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[43]  M. Teh,et al.  Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes , 2010, Molecular Cancer.

[44]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[45]  Juan M. Vaquerizas,et al.  A census of human transcription factors: function, expression and evolution , 2009, Nature Reviews Genetics.

[46]  A. Godwin,et al.  Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. , 2008, Cancer research.

[47]  Arndt Hartmann,et al.  Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer , 2008, BMC Cancer.

[48]  Olufunmilayo I. Olopade,et al.  Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.

[49]  M. Esteller.  Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[50]  C. Prives,et al.  Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? , 2007, Oncogene.

[51]  J. Jónasson,et al.  Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer , 2006, Breast Cancer Research.

[52]  M. Fraga,et al.  Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  L. Trümper.  From bench to bedside , 2005, Medizinische Klinik.

[54]  C. Pilarsky,et al.  Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. , 2004, Neoplasia.

[55]  S. McMahon,et al.  Analysis of genomic targets reveals complex functions of MYC , 2004, Nature Reviews Cancer.

[56]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[57]  M. Bulyk.  Computational prediction of transcription-factor binding site locations , 2003, Genome Biology.

[58]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[59]  Xin Chen,et al.  TRANSFAC: an integrated system for gene expression regulation , 2000, Nucleic Acids Res..

[60]  B. Biesecker,et al.  Breast cancer susceptibility genes. BRCA1 and BRCA2. , 1998, Medicine.

[61]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .

[62]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[63]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.